The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Haddadin Yezan Munther since 2020.
This trader's CIK number is 1718004.
At the time of last reporting, Haddadin Yezan Munther was the Officer of Outlook Therapeutics, Inc.. (stock ticker symbol OTLK).
Also see all insider trading activities at Outlook Therapeutics, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2024 | OTLK | 1,881 | $22,233 | 0 | $0 | 0 | $0 |
2021 | OTLK | 20,000 | $32,099 | 0 | $0 | 0 | $0 |
2020 | OTLK | 10,000 | $7,250 | 0 | $0 | 0 | $0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2024-03-28 | OTLK | Buy | 1,881 | 11.82 | 22,233 |
2021-12-02 | OTLK | Buy | 10,000 | 1.39 | 13,899 |
2021-04-19 | OTLK | Buy | 10,000 | 1.82 | 18,200 |
2020-09-22 | OTLK | Buy | 10,000 | .72 | 7,250 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Haddadin Yezan Munther (Officer of Outlook Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.